Sanofi
Sanofi will implement BenchSci's Ascend across its global research organization.
The company's platform predicts how people in a clinical trial will respond to treatment.
The AI-powered COPD care coordination tool uses EHR data and natural language processing to identify and manage high-risk patients.
Sanofi invests in Zucara Therapeutics and MintNeuro raises $1.27 million in a funding round.
Sanofi head of organization capability and transformation, Felix Lee, discusses how the pharma giant leverages digital therapeutics company DarioHealth to complement its drug offerings and enhance patient care and self-management.
The alliance will expand Sanofi's trek into tech-based drug discovery and development platforms.
HIMSS22 Europe
Tarja Stenvall, SVP of key markets and general medicines at Sanofi, discusses why well-informed and engaged patients are crucial and how less red tape can turn into better patient engagement.
They will deliver connected caps for insulin and titration alerts to Japanese healthcare providers and patients.
The agreement also allows the companies to develop new or improved tools for Dario's chronic condition management platform.
This news comes just months after Exscientia went public.